Cancer Center Administration Cancer Center Administration provides the resources and support necessary to achieve the highest standards of excellence for the UMCCC research enterprise. This is accomplished through an effective infrastructure that provides efficient, timely and streamlined assistance to Cancer Center leadership and members. The specific responsibilities of the administrative core are as follows: Provide full-service administrative support to the Cancer Center Director, senior leadership, program and core leaders and membership Provide strategic input and support to implement the strategic plan in concert with UMCCC leadership Manage all Cancer Center finances, space, personnel, grants and equipment Oversee membership, annual space and core reviews and pilot grant awards Oversees the operation of sixteen UMCCC Cores, including the new cores in Bioinformatics and Health Communications that received considerable assistance from CC administration in their implementation. Coordinate and execute research administration functions in support of the planning and evaluation efforts of the Center Serve as effective communicator between UMCCC leadership and members, serving as a problem solver and facilitator to stimulate innovative, collaborative cancer research Develop and implement initiatives to address disparities in cancer care in minority populations served by the UMCCC Maintain strong ties to the community through education and outreach activities Cancer Center Administration manages 86 staff (excluding clinical operations), a budget of $34,275,129 (excluding clinical revenues) and space that will total 240,661 sq ft in 2006.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-20
Application #
7726818
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
20
Fiscal Year
2007
Total Cost
$334,074
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Feng, Mary; Suresh, Krithika; Schipper, Matthew J et al. (2018) Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. JAMA Oncol 4:40-47
Xiong, Yi; Torsoni, Adriana Souza; Wu, Feihua et al. (2018) Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases. Elife 7:
El Kadi, Najwa; Wang, Luo; Davis, April et al. (2018) The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer. Cancer Res 78:6728-6735
Namkoong, Sim; Ho, Allison; Woo, Yu Mi et al. (2018) Systematic Characterization of Stress-Induced RNA Granulation. Mol Cell 70:175-187.e8
Thomas, Tina T; Chukkapalli, Sahiti; Van Noord, Raelene A et al. (2018) Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts. J Vis Exp :
Eisenberg, Marisa C; Campredon, Lora P; Brouwer, Andrew F et al. (2018) Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study. BMJ Open 8:e021618
Johnson, Allison M; Roach, James P; Hu, Anna et al. (2018) Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure. FASEB J 32:2615-2629
Feinberg, Tamar Y; Zheng, Huarui; Liu, Rui et al. (2018) Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs. Dev Cell 47:145-160.e6
Boonstra, Philip S; Barbaro, Ryan P (2018) Incorporating historical models with adaptive Bayesian updates. Biostatistics :
Subramanian, Chitra; Grogan, Patrick T; Opipari, Valerie P et al. (2018) Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-?B activation. Oncotarget 9:14509-14523

Showing the most recent 10 out of 1493 publications